Generic drugmaker Teva names Frost as chairman

Generic drugmaker Teva Biologic Industries Ltd. said Tuesday it has appointed carnality administrator Dr. Phillip Frost to serve as administrator of its board.

The world's better all-encompassing drugmaker by acquirement said Frost will alter Moshe Many, who had been confined as acting administrator and will now serve as carnality chairman.

The moves came as Teva said above Administrator Eli Hurvitz told the aggregation that he wants to be appear from his duties at Teva in adjustment to focus on his abounding recovery.

The Israeli aggregation appear aftermost ages that Hurvitz was demography a leave of absence for about three weeks to ameliorate from analysis for a afresh diagnosed illness.

Frost had served as carnality administrator of Teva's lath back 2006. He additionally serves as administrator and CEO of Opko Health Inc., a specialty biologic company, and as administrator of Prolor Biotech and Ladenburg Thalmann Financial Services.

Teva sells some brand-name drugs and additionally challenges the patents of others to get approval to advertise all-encompassing versions afore the patents expire.

The aggregation says 80 percent of its sales appear from North America and Western Europe.

Last month, Teva said it becoming $2 billion, or $2.23 per share, aftermost year, up from $609 million, or 75 cents per share, in 2008. Acquirement rose to $13.9 billion from $11.09 billion.

Teva shares rose 83 cents, or 1.4 percent, to $61.32 in backward morning trading Tuesday.

 

Related posts about Generic Drugmaker Teva Names Frost As Chairman